Working to find actionable solutions to the nation's key challenges.

Educational Series on Affordable Medicines: Impact of Federal Policy on Innovation, Competition, and Costs


WHEN: Tuesday, May 10, 2016 6:00 a.m. to 7:30 a.m. ET

WHERE: Bipartisan Policy Center, 1225 Eye St. NW, Suite 1000, Washington, DC, 20005

Share on FacebookTweet about this on TwitterShare on LinkedInPin on PinterestShare on TumblrEmail this to someonePrint this page
Add to Calendar

Event Recap: How Federal Policies Impact Innovation and Costs of Pharmaceutical Therapies

The Bipartisan Policy Center is hosting three educational forums to inform the national conversation on affordable medicines. The purpose of these forums is to seek an understanding of how private sector decisions and public sector policies impact the prices of drugs and their costs to the health care system. They will highlight what is known about the present system and explore the full range of viewpoints on this issue. BPC hopes each convening will explore how best to support medical innovation while ensuring access and affordability for patients.

The second forum addressed how existing federal statutes and regulations impact pharmaceutical innovation, market competition, and costs.

Join the discussion on Twitter: @BPC_Bipartisan #BPClive

Keynote remarks by:

Gerard Anderson, PhD
Professor of Health Policy and Management, Johns Hopkins University Bloomberg School of Public Health
View presentation slides

Panel discussion with:

Scott Gottlieb, M.D.
Resident Scholar, American Enterprise Institute
Former Deputy Commissioner, U.S. Food and Drug Administration

Tim Gronniger
Deputy Chief of Staff, Centers for Medicare & Medicaid Services

Paul Howard
Senior Fellow and Director of Health Policy, Manhattan Institute

Matt Salo
Executive Director, National Association of Medicaid Directors

Moderated by:

Sheila Burke
Strategic Advisor, Baker Donelson